APA

Milone M. R., Pucci B., Bruzzese F., Carbone C., Piro G., Costantini S., Capone F., Leone A., Di Gennaro E., Caraglia M. & Budillon A. (20131023). Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. : Cell death & disease.

Chicago

Milone M R, Pucci B, Bruzzese F, Carbone C, Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M and Budillon A. 20131023. Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. : Cell death & disease.

Harvard

Milone M. R., Pucci B., Bruzzese F., Carbone C., Piro G., Costantini S., Capone F., Leone A., Di Gennaro E., Caraglia M. and Budillon A. (20131023). Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. : Cell death & disease.

MLA

Milone M R, Pucci B, Bruzzese F, Carbone C, Piro G, Costantini S, Capone F, Leone A, Di Gennaro E, Caraglia M and Budillon A. Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells. : Cell death & disease. 20131023.